FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/078131 [Registered on: 16/12/2024] Trial Registered Prospectively
Last Modified On: 13/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Comparison of laparoscopic totally extraperitoneal hernia repair with and without prophylactic antibiotics. 
Scientific Title of Study   Comparison of laparoscopic totally extraperitoneal hernia repair with and without prophylactic antibiotics: A randomized controlled study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ananya Dilip 
Designation  Post graduate resident doctor 
Affiliation  Maulana Azad Medical College and Associated Lok Nayak Hospital 
Address  Department of Surgery Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi - 110002 Central DELHI 110002 India

Central
DELHI
110002
India 
Phone  9971428110  
Fax    
Email  ananyadilip123@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Anubhav Vindal 
Designation  Professor 
Affiliation  Maulana Azad Medical College And Associated Lok Nayak Hospital 
Address  Department of Surgery Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi - 110002 Central DELHI 110002 India

Central
DELHI
110002
India 
Phone  9968604403  
Fax    
Email  anubhav.vindal@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Ananya Dilip 
Designation  Post graduate resident doctor 
Affiliation  Maulana Azad Medical College And Associated Lok Nayak Hospital 
Address  Department of Surgery Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi - 110002 Central DELHI 110002 India

Central
DELHI
110002
India 
Phone  9971428110  
Fax    
Email  ananyadilip123@gmail.com  
 
Source of Monetary or Material Support  
Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi -110002 
 
Primary Sponsor  
Name  Maulana Azad Medical College and Associated Lok Nayak Hospital 
Address  Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi 110002 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ananya Dilip  Lok Nayak Hospital  Department of Surgery Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi - 110002 Central DELHI 110002 India
New Delhi
DELHI 
9971428110

ananyadilip123@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee, Maulana Azad Medical college and associated hospitals  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K409||Unilateral inguinal hernia, without obstruction or gangrene,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Patient receiving placebo(10ml of normal saline)  The patients will be informed about randomization and possibility of being allotted to any of the 2 groups and consent for participation obtained. All patients will undergo antibiotic sensitivity testing as a part of their preoperative preparation. Patients will be randomized at induction of anesthesia. The anesthetist will be given 2 syringes marked A (1.2 g of Inj. Amoxyclav reconstituted in 10ml of normal saline) and B (placebo-10ml of normal saline).The staff nurse will be asked to pull out a sealed envelope which will reveal patient’s allocation into one of the two groups and enter the same in an allocation table, which will be reviewed by the primary researcher only at the end of the study. The anesthetist will administer one of the two syringes based on this allocation without the knowledge of operating surgeon or primary researcher. All patients will undergo laparoscopic inguinal hernia(TEP) repair by the same primary surgeons in a day care setting. 
Intervention  Patient receiving single dose of pre operative prophylactic antibiotic ( Inj. Amoxyclav 1.2 mg IV )  The patients will be informed about randomization and possibility of being allotted to any of the 2 groups and consent for participation obtained. All patients will undergo antibiotic sensitivity testing as a part of their preoperative preparation. Patients will be randomized at induction of anesthesia. The anesthetist will be given 2 syringes marked A (IV injection of 1.2 g of Inj. Amoxyclav reconstituted in 10ml of normal saline) and B (placebo-10ml of normal saline).The staff nurse will be asked to pull out a sealed envelope which will reveal patient’s allocation into one of the two groups and enter the same in an allocation table, which will be reviewed by the primary researcher only at the end of the study. The anesthetist will administer one of the two syringes based on this allocation without the knowledge of operating surgeon or primary researcher. All patients will undergo laparoscopic inguinal hernia(TEP) repair by the same primary surgeons in a day care setting.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  All patients of symptomatic inguinal hernia presenting to surgery outpatient department at Lok Nayak Hospital, New Delhi and planned for laparoscopic inguinal hernia surgery 
 
ExclusionCriteria 
Details  1. Recurrent inguinal hernia,
2. Antibiotic intake 48 hours prior to surgery ,
3. Evidence of diabetes mellitus, other immunocompromised states and conversion to open procedure and
4. Pregnancy or lactation 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Incidence of SSI (evidenced by development of redness, swelling, discharge or increase in pain over staple line in a period of 30 days post op) as defined by CDC classification.  At 48hrs,1week,2week,4 weeek 
 
Secondary Outcome  
Outcome  TimePoints 
Post operative pain using Visual Analogue
Scale (VAS) score 
At 6 hours,discharge,24 hours,1 week 
Duration of hospital stay   Pre, intra and post procedure 
Patient satisfaction (Likert scale)  At discharge, 1 week, 4 weeks 
Post operative complications (Clavien Dindo classification)  48hours, 1 week,2 week, 4 weeks 
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   24/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Open to Recruitment 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Despite extensive research in literature regarding randomized controlled studies evaluating the efficacy of prophylactic antibiotics in laparoscopic totally extraperitoneal repair (TEP), we were unable to find any. The only studies were observational or evaluated the role in open inguinal hernia repairs.Hence, the present study was designed to assess the role of prophylactic antibiotics in laparoscopic inguinal hernia repair.The Guidelines of the European Hernia Society for the treatment of inguinal hernia concluded that antibiotic prophylaxis does not significantly reduce the number of wound infection.
This is a randomized placebo-controlled study designed  to evaluate the role of  prophylactic antibiotics in laparoscopic totally extraperitoneal hernia repair at a single center in New Delhi, India. The primary outcome measures will be occurence of surgical site infection (CDC classification) .The secondary outcomes will be  post operative complications, post operative pain , duration of hospital stay and patient satisfaction. 
 
Close